Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio)

Journal of Applied Toxicology

Volumn 35, Issue 3, 2015, Pages 241-252

  Han, Ying ^a   Zhang, Jing pu ^a   Qian, Jian qin ^b   Hu, Chang qin ^b  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Alternative animal model; Anthracycline; Cardiac genes; Cardiotoxicity; Zebrafish embryo

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; PIRARUBICIN; ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HEART DEVELOPMENT; LC50; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; ZEBRA FISH; ANIMAL; ANIMAL EMBRYO; CHEMICALLY INDUCED; CONGENITAL HEART MALFORMATION; DOSE RESPONSE; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; HEART RATE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA; DANIO RERIO; FORMICIDAE; MAMMALIA;

ANIMALS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CARDIOTOXICITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, NONMAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DEFECTS, CONGENITAL; HEART RATE; ZEBRAFISH;

EID: 84921767175     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3007     Document Type: Article

References (52)

1. Antkiewicz DS, Burns CG, Carney SA, Peterson RE, Heideman W. 2005. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. 84: 368-377.
2. Bakkers J. 2011. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc. Res. 91: 279-288.
3. Baud FJ, Megarbane B, Deye N, Leprince P. 2007. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit. Care 11: 207.
4. Berdougo E, Coleman H, Lee DH, Stainier DY, Yelon D. 2003. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development 130: 6121-6129.
5. Berthiaume JM, Wallace KB. 2007. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol. Toxicol. 23: 15-25.
6. Carney SA, Chen J, Burns CG, Xiong KM, Peterson RE, Heideman W. 2006. Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish. Mol. Pharmacol. 70: 549-561.
7. Chen J, Carney SA, Peterson RE, Heideman W. 2008. Comparative genomics identifies genes mediating cardiotoxicity in the embryonic zebrafish heart. Physiol. Genomics 33: 148-158.
8. Chen YH, Lee HC, Hsu RJ, Chen TY, Huang YK, Lo HC, Hu SC, Harn HJ, Jeng JR, Sun CK, Lin SZ, Tsai HJ. 2012. The toxic effect of Amiodarone on valve formation in the developing heart of zebrafish embryos. Reprod. Toxicol. 33: 233-244.
9. Clark DE. 2011. What has polar surface area ever done for drug discovery? Future Med. Chem. 3: 469-484.
10. Ertl P, Rohde B, Selzer P. 2000. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43: 3714-3717.
11. Goerigk L, Grimme S. 2011. A thorough benchmark of density functional methods for general main group thermochemistry, kinetics, and noncovalent interactions. Phys. Chem. Chem. Phys. 13: 6670-6688.
12. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. 2012. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4: 17.
13. Hung MW, Zhang ZJ, Li S, Lei B, Yuan S, Cui GZ, Man Hoi P, Chan K, Lee SM. 2012. From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound. Evid. Based Complement. Alternat. Med. 2012: 605303.
14. Incardona JP, Collier TK, Scholz NL. 2004. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 196: 191-205.
15. Kannankeril P, Roden DM, Darbar D. 2010. Drug-induced long QT syndrome. Pharmacol. Rev. 62: 760-781.
16. Killeen MJ. 2009. Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry. Drug Discov. Today 14: 589-597.
17. Li S, Pozhitkov A, Ryan RA, Manning CS, Brown-Peterson N, Brouwer M. 2010. Constructing a fish metabolic network model. Genome Biol. 11: R115.
18. Mathias JR, Saxena MT, Mumm JS. 2012. Advances in zebrafish chemical screening technologies. Future Med. Chem. 4: 1811-1822.
19. Menna P, Paz OG, Chello M, Covino E, Salvatorelli E, Minotti G. 2012. Anthracycline cardiotoxicity. Expert Opin. Drug Saf. 11(Suppl. 1): S21-36.
20. Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. 2011. Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Expert Opin. Drug Metab. Toxicol. 7: 707-720.
21. Neese F. 2012. The ORCA program system. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2: 73-78.
22. Neidle S, Taylor G. 1977. Nucleic acid binding drugs. Part IV. The crystal structure of the anti-cancer agent daunomycin. Biochim. Biophys. Acta 479: 450-459.
23. Ng WA, Grupp IL, Subramaniam A, Robbins J. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68: 1742-1750.
24. Peterkin T, Gibson A, Patient R. 2007. Redundancy and evolution of GATA factor requirements in development of the myocardium. Dev. Biol. 311: 623-635.
25. Peterson RT, Fishman MC. 2011. Designing zebrafish chemical screens. Methods Cell Biol. 105: 525-541.
26. Pouna P, Bonoron-Adele S, Gouverneur G, Tariosse L, Besse P, Robert J. 1996. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention. Br. J. Pharmacol. 117: 1593-1599.
27. Rahman AM, Yusuf SW, Ewer MS. 2007. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int. J. Nanomed. 2: 567-583.
28. Raschi E, Vasina V, Ursino MG, Boriani G, Martoni A, De Ponti F. 2009. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacol. Ther. 125: 196-218.
29. Robert J. 2007. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls. Cell Biol. Toxicol. 23: 27-37.
30. Robert J, Gianni L. 1993. Pharmacokinetics and metabolism of anthracyclines. Cancer Surv. 17: 219-252.
31. Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, Burns CG, Katus HA, Fishman MC. 2006. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ. Res. 99: 323-331.
32. Sawyer DB, Peng X, Chen B, Pentassuglia L, Lim CC. 2010. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog. Cardiovasc. Dis. 53: 105-113.
33. Schaftenaar G, Noordik JH. 2000. Molden: a pre- and post-processing program for molecular and electronic structures. J. Comput. Aided Mol. Des. 14: 123-134.
34. Scholz S. 2012. The zebrafish has become an attractive model organism in many areas of research ranging from basic developmental biology to applied toxicology. Reprod. Toxicol. 33: 127.
35. Sinnecker S, Rajendran A, Klamt A, Diedenhofen M, Neese F. 2006. Calculation of solvent shifts on electronic g-tensors with the conductor-like screening model (COSMO) and its self-consistent generalization to real solvents (direct COSMO-RS). J. Phys. Chem. A 110: 2235-2245.
36. Smith KA, Chocron S, von der Hardt S, de Pater E, Soufan A, Bussmann J, Schulte-Merker S, Hammerschmidt M, Bakkers J. 2008. Rotation and asymmetric development of the zebrafish heart requires directed migration of cardiac progenitor cells. Dev. Cell 14: 287-297.
37. Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A. 2010. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10: 337.
38. Sukardi H, Chng HT, Chan EC, Gong Z, Lam SH. 2011. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opin. Drug Metab. Toxicol. 7: 579-589.
39. Sultana N, Nag K, Hoshijima K, Laird DW, Kawakami A, Hirose S. 2008. Zebrafish early cardiac connexin, Cx36.7/Ecx, regulates myofibril orientation and heart morphogenesis by establishing Nkx2.5 expression. Proc. Natl. Acad. Sci. U.S.A. 105: 4763-4768.
40. Takaki K, Cosma CL, Troll MA, Ramakrishnan L. 2012. An in vivo platform for rapid high-throughput antitubercular drug discovery. Cell Rep. 2: 175-184.
41. Targoff KL, Schell T, Yelon D. 2008. Nkx genes regulate heart tube extension and exert differential effects on ventricular and atrial cell number. Dev. Biol. 322: 314-321.
42. Valdivieso M, Kujawa AM, Jones T, Baker LH. 2012. Cancer survivors in the United States: a review of the literature and a call to action. Int. J. Med. Sci. 9: 163-173.
43. van Noord C, Eijgelsheim M, Stricker BH. 2010. Drug- and non-drug-associated QT interval prolongation. Br. J. Clin. Pharmacol. 70: 16-23.
44. Weigend F. 2006. Accurate Coulomb-fitting basis sets for H to Rn. Phys. Chem. Chem. Phys. 8: 1057-1065.
45. Weigend F, Ahlrichs R. 2005. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy. Phys. Chem. Chem. Phys. 7: 3297-3305.
46. Westerfield M. 2007. The Zebrafish Book: a guide for the laboratory use of zebrafish (Danio rerio). University of Oregon Press: Eugene. OR; 1 v. (various pagings).
47. Working PK, Newman MS, Sullivan T, Yarrington J. 1999. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. J. Pharmacol. Exp. Ther. 289: 1128-1133.
48. Yelon D. 2001. Cardiac patterning and morphogenesis in zebrafish. Dev. Dyn. 222: 552-563.
49. Yelon D, Horne SA, Stainier DY. 1999. Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish. Dev. Biol. 214: 23-37.
50. Yuan Y, Zhao Y, Xin S, Wu N, Wen J, Li S, Chen L, Wei Y, Yang H, Lin S. 2013. A novel PEGylated liposome-encapsulated SANT75 suppresses tumor growth through inhibiting hedgehog signaling pathway. PLoS One 8: e60266.
51. Zhang J, Qian J, Tong J, Zhang D, Hu C. 2013. Toxic effects of cephalosporins with specific functional groups as indicated by zebrafish embryo toxicity testing. Chem. Res. Toxicol. 26: 1168-1181.
52. Zhao Y, Samal E, Srivastava D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220.